The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded $590 million from the U.S. Health and Human Services Department to speed up the ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...